Epicor and Microsoft to partner on intelligent cloud project
The firm confirmed the news at it’s...
The US-based global software company, Epicor, has announced its partnership with the technology giant Microsoft.
The firm confirmed the news at it’s annual Insights conference, noting the deal would see Epicor deliver its enterprise-class solutions to Microsoft’s Azure platform.
Initially, Epicor will standardise cloud deployment of it’s ERP and Prophet 21® suites, allowing resource planning to aid fast growth and innovation for customers aiming to digitally transform their businesses.
“Microsoft's focus on the ‘Intelligent Cloud’ and ‘Intelligent Edge’ complement our customer-centric focus," remarked Steve Murphy, CEO of Epicor.
“We looked at several public cloud options. Microsoft Azure offers the best foundation for building and deploying enterprise business applications that will enable our customers' businesses to adapt and grow.”
“Today, we are seeing more than three-quarters of prospects ask about cloud ERP.”
“As that deployment model becomes the norm, we are ready to enable our customers to move to the cloud with confidence leveraging the reliability, security, and scalability of Microsoft Azure.”
“Standardizing cloud deployment of its world-class manufacturing and distribution solutions on Microsoft Azure is a natural step for Epicor with its history of leveraging forward-looking technology to deliver the utmost value to its customers,” stated David Willis, Corporate Vice President of Microsoft.
“With Epicor solutions running in the cloud, customers will reap the benefits of greater agility, faster innovation, and favorable economics of Azure as they embrace digital transformation.”
IMF: Variants Can Still Hurt Manufacturing Recovery
After a year of on-and-off manufacturing in the US, UK, and the eurozone, demand for goods surged early last week. Factories set growth records in April and May, suppliers started to recover, and US crude hit its highest price point since pre-COVID. As vaccination efforts immunise much of the US and UK populations, manufacturers are now able to fully ramp up their supply chains. In fact, GDP growth could approach double-digits by 2022.
Now, the ISM productivity measure has surpassed the 50-point mark that separates industry expansion from contraction. Since U.S. president Biden passed his US$1.9tn stimulus package and the UK purchasing managers index (PMI) increased to 65.6, both sides of the Atlantic are facing a much-welcomed manufacturing recovery.
Lingering Concerns Over COVID
Even as Spain, France, Italy, and Germany race to catch up, and mining companies pushed the FTSE 100 index of list shares to a monthly high of 7,129, some say that UK and US markets still suffer from a lack of confidence in raw material supplies. Yes, the Dow Jones has made up its 19,173-point crash of March 2020, and MSCI’s global stock index is at an all-time high.
Yet manufacturers around the world realise that these wins will be short-lived until pandemic supply chain bottlenecks are solved. If we keep the status quo, consumers will pay the price. In April, inflation in Germany reached 2.4%, and across the EU’s 19 member countries, overall prices have increased at an unusual pace. Some ask: Is this true recovery?
IMF: Current Boom Could Falter
Even as Elon Musk tweeted about chip shortages forcing Tesla to raise its prices, UK mining demand skyrocketed; housing markets lifted; and the pound sterling gained value. The International Monetary Fund (IMF), however, cautioned that manufacturing recovery won’t last long if COVID mutates into forms our vaccinations can’t touch. Kristalina Georgieva, Washington’s IMF director, noted that fewer than 1% of African citizens have been vaccinated: “Worldwide access to vaccines offers the best hope for stopping the coronavirus pandemic, saving lives, and securing a broad-based economic recovery”.
Across the globe, manufacturing companies are keeping a watchful eye on new developments in the spread of COVID. Though US FDA officials don’t think we’ll have to “start at square one” with new vaccines, the March 2021 World Economic Outlook states that “high uncertainty” surrounds the projected 6% global growth. Continued manufacturing success will in large part depend on “the path of the pandemic, the effectiveness of policy support, and the evolution of financial conditions”.
Mathias Cormann, secretary-general of the Organisation for Economic Co-Operation and Development (OECD) concurred—without global immunisation, the estimated economic boom expected by 2025 could go kaput. “We need to...pursue an all-out effort to reach the entire world population”, Australia’s finance minister added. US$50bn to end COVID across the world, they imply, is a small investment to restart our economies.